日本財団 図書館


F-1-02-03

BIO-MAGNETIC FIELD THERAPY IN PAIN MANAGEMENT

Jan P. Everett (Faculty of Medicine, University of Indonesia, Jakarta. Indonesia)

 

This study is to find out the efficacy of Bio-Magnetic Field Therapy in alleviating or relieving pain. All patients who came to our Center with Pain which cannot be controlled by NSAID or Physical Therapy were given Flexible Magnetic Pads which comes in several sizes, forms and below 1000 gauss in intensity. Our patients ranging from Sports Injured fractured metatarsal and metacarpal bones, Rheumatoid and Osteoarthritic patient. In 12 patients, pain disappeared completely in 1 or 2 hours and in 36 patients pain was reduced to 10 % in Visual Analog Scale (VAS) within 6 - 8 hours after the application of Bio-Magnetic Field Therapy (BMFT) pad and in another 32 patients pain was reduced only to 40 - 50 % in VAS. In this particular group of patients which is dominated by chronic Osteoarthritic with severe mechanical disturbance in their knees, we resumed Physical Therapy and NSAID's which were different from what were given to them previously. In our observation, pain was lessened only by 10-20% in VAS. But after we have repaired the mechanics of the knees by giving Iron bar hinged Knee Braces in 2 to 3 days the pain disappeared 100%.

We concluded that the use of Bio-Magnetic Field Therapy in Pain Management is very effective alternative Therapy.

 

F-1-02-04

TREATMENT OF PAIN BY INTRATHECAL APPLICATION OF ANALGESIC

Drazen Kvesic, V.Nankovic, G. Buljat, M.Cvjetko, Z.Kejla

(Universitiy Clinic for Traumatology, Zagreb, Croatia)

 

Purpose. To investigate the efficacy of intrathecal drug delivery, in management of chronic, intractable pain syndromes.

Method. Twenty eight patients were treated for chronic, intractable pain syndromes curing 1994- 1996. Five patients were supplied with a subcutaneous programmable pump (Synchromed) for continuous application, and twenty-three patients had an implantation of subcutaneous system (Spinoplant) for bolus application of their medication. Twenty-seven patients were treated for metastatic cancer and one patient for failed back syndrome. Result. Average survival time was 14 months. Satisfactory results were obtained in all patients as confirmed with VAS scale.

Conclusion. Subcutaneous systems for intrathecal application of analgesics are safe and effective means of pain control in otherwise refractory pain syndromes.

 

 

 

BACK   CONTENTS   NEXT

 






日本財団図書館は、日本財団が運営しています。

  • 日本財団 THE NIPPON FOUNDATION